Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Trial
Endocrine
2025
Efficacy and safety of denosumab biosimilar CMAB807 versus Prolia
Yan Jiang et al.
PubMed ↗
Publisher ↗
No numbers read from the abstract.
Not cited yet
Efficacy and safety of denosumab biosimilar CMAB807 versus Prolia | OpenQuestion